Research Desk

TPL combines unhedged Permian royalties, a growing water and surface-use business and about 88% EBITDA margins with almost no debt. The share price is about 34% below its February high, while volumes are at records and the data center and power pipeline is widening.

A global franchise model with a 50-year dividend record trades near a four-year low on one weak U.S. quarter. If value and loyalty efforts stabilise traffic, the multiple has room to recover while the dividend pays the holder to wait.

FCX trades near record highs on a copper price propped up by US tariff stockpiling and a flawless Grasberg ramp. A looser copper market or another Indonesia slip would compress both the commodity and the multiple.

AWS growth has accelerated for five straight quarters, and advertising and retail margin gains are adding to profit. The shares sit about 11% below the August record, which leaves room if the capex spend converts to revenue.

AMD's data-center mix is shifting toward MI450/Helios GPUs and share-gaining EPYC CPUs, with gigawatt-scale customer commitments giving unusual visibility into 2027. Q4 2026 to Q1 2027 is when that visibility turns into reported revenue.

UNH is converting repricing and benefit cuts into a lower medical cost ratio faster than the Street modeled, and a better-than-feared 2027 Medicare Advantage rate sets up a second year of earnings recovery. At about 19x 2026 guidance, the stock still sits roughly 18% below its July high.

After a roughly 40% drawdown, NVO trades near 11x forward earnings with a 4.8% yield. That prices in permanent share loss to Lilly, even though volumes are growing and the Wegovy pill is the strongest GLP-1 launch by volume in the US. A modest sentiment repair would be enough to rerate it.

NOW still trades at a premium software multiple while guidance points to a clear growth step-down in Q3, and Q2 was flattered by FX and a federal pull-forward. Enterprise budget scrutiny and the shift from seat pricing to AI consumption pricing leave little room for a miss on growth or margin.

SPHR is priced as a scalable venue platform, but Las Vegas still depends on one show whose ticket yield is fading while the expansion plan needs more capital and content. Q2 profit already fell as revenue grew, which is the pattern a high-fixed-cost venue shows when utilization or pricing slips.

NVDA trades at record highs on the assumption that roughly 75% gross margins and hyperscaler spending both keep compounding. Guidance already shows margin and sequential growth slipping, and revenue depends on a few buyers who are building their own chips.

The market prices Circle as a rate-cut casualty, but the Fed is now hiking, USDC supply is still growing, and GENIUS Act licensing favors a regulated incumbent. Reserve income looks more durable than the stock's 47% drawdown from its 52-week high implies.

Search is growing faster with AI, and Google Cloud is accelerating with rising margins. The stock sits about 15% below its May high after a capex-driven pullback. Courts have also now declined to break the company up.

Opendoor's turnaround needs housing turnover to cooperate, and mortgage rates at a multi-year high are pushing the other way. Management has already cut its Q3 guide and pushed back the profit timeline, and the year-end adjusted net income (ANI) target is exposed to further slippage.

WAL's margin and earnings recovery relies on funding-cost relief and clean credit, but the Fed has just turned to hiking and the deposit base is costly and shrinking. Shares at about 1.2x tangible book already assume a credit clean-up, so any new loan losses or deposit slippage leaves limited cushion.

Q2 revenue growth was bought with a lower-quality mix, and the profit and cash-flow outlook is deteriorating. Open FTC and securities litigation, a still-unsettled compounding and peptide rule set, and cheaper branded GLP-1 competition leave the shares exposed.

The Q2 beat was priced before mortgage rates reversed. Existing-home volumes are now below the level behind management's base-case EBITDA, and the company carries 3.3x leverage while it integrates Anywhere.

JPM is compounding revenue across NII, investment banking and markets while card credit costs improve, and it holds excess capital to return. At roughly 14x trailing earnings, the shares sit about 10% below the Street's average target and below the August high.

Affirm is growing volume at more than 30% while margins expand and funding costs fall, and the shares trade below the street target on a business that is now GAAP profitable. If credit holds, operating leverage should carry earnings faster than the market is pricing.

A fuel-price shock is pulling US buyers toward EVs just as Rivian's R2 widens its addressable market, and record deliveries show demand holding up without subsidies. At about 3.9x trailing revenue and 36% below the 52-week high, the shares price in a stumble on the Q4 R2 ramp.